A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 3
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 100
- Population
- ALL · 55 Years
- Duration
- 2000-12-01 to 2001-11-01
- Intervention
- Buprenorphine transdermal delivery system
- Comparator
- Not reported
- Outcomes measured
- Pilot study.; The following outcome variables were assessed:; average pain intensity in the last 24 hours; acceptability of analgesic therapy; number of nighttime awakenings due to pain last night; quality of sleep; bowel status during the last 24 hours; pain management evaluation; symptom evaluation; staff evaluation of functional independence; resident-defined activity impairment scale; treatment satisfaction questionnaire; Health Assessment Questionnaire; Timed "Up & Go" evaluation; trail making test; digit span test; end of study global evaluation of therapeutic response; modified mini-mental state; examination and geriatric depression scale.; The following measures of health resource utilization were assessed:
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Chronic pain and ageing · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.
